A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia

SIMPLE SUMMARY: The introduction of venetoclax (VEN) to combination regimens has dramatically changed the paradigm of treatment for acute myeloid leukemia (AML) patients deemed unfit for intensive chemotherapy. Several researchers have reported that this regimen was successfully used as a bridge to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, Su-Yeon, Park, Silvia, Kwag, Daehun, Lee, Jong Hyuk, Min, Gi-June, Park, Sung-Soo, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Min, Chang-Ki, Cho, Seok-Goo, Lee, Jong Wook, Kim, Hee-Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046472/
https://www.ncbi.nlm.nih.gov/pubmed/36980551
http://dx.doi.org/10.3390/cancers15061666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046472/
https://www.ncbi.nlm.nih.gov/pubmed/36980551
http://dx.doi.org/10.3390/cancers15061666

Ejemplares similares